Page last updated: 2024-08-21

arsenic trioxide and Atherogenesis

arsenic trioxide has been researched along with Atherogenesis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Fang, S; Hao, X; Li, H; Liang, C; Sun, B; Sun, S; Wan, X; Yu, B; Zhang, F; Zhang, Z; Zou, X1
Mann, KK; Molina, MF; Padovani, AM1

Other Studies

2 other study(ies) available for arsenic trioxide and Atherogenesis

ArticleYear
Arsenic trioxide induces macrophage autophagy and atheroprotection by regulating ROS-dependent TFEB nuclear translocation and AKT/mTOR pathway.
    Cell death & disease, 2021, 01-18, Volume: 12, Issue:1

    Topics: Animals; Apoptosis; Arsenic Trioxide; Atherosclerosis; Autophagy; Cell Nucleus; Humans; Macrophages; Male; Mice; Proto-Oncogene Proteins c-akt; RAW 264.7 Cells; Reactive Oxygen Species; Signal Transduction; THP-1 Cells; TOR Serine-Threonine Kinases; Transfection

2021
Inhibition of liver x receptor/retinoid X receptor-mediated transcription contributes to the proatherogenic effects of arsenic in macrophages in vitro.
    Arteriosclerosis, thrombosis, and vascular biology, 2010, Volume: 30, Issue:6

    Topics: Animals; Apolipoprotein A-I; Arsenic Trioxide; Arsenicals; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Binding Sites; Biological Transport; Chlorocebus aethiops; Cholesterol; Chromatin Immunoprecipitation; Co-Repressor Proteins; COS Cells; Cyclic AMP; DNA-Binding Proteins; Dose-Response Relationship, Drug; Humans; Liver X Receptors; Macrophages; Mice; Orphan Nuclear Receptors; Oxides; Promoter Regions, Genetic; Protein Multimerization; Retinoid X Receptor alpha; Retinoid X Receptor beta; RNA Interference; RNA, Messenger; Signal Transduction; Sterol Regulatory Element Binding Protein 1; Transcriptional Activation; Transfection

2010